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a B S T r a c T
Endobronchial ultrasound (EBUS) has revolutionized the field of bronchoscopy because it allows to observe peribronchial structures and distal 
peripheral lung lesions. The use of EBUS was first described by Hurte and Hanrath in 1992. EBUS technology exists in two forms: radial and 
convex transducer probes. The radial EBUS probe has a 20-MHZ (12-30 MHz available) rotating transducer that can be inserted together with 
or without a guide sheath through the working channel (2.0-2.8 mm) of a standard flexible bronchoscope. The transducer rotates and produces 
a 360-degree circular image around the central position of the probe. There are two types of radial EBUS probes: “peripheral” probes, used to 
identify parenchymal lung lesions, and “central” probes, with balloon sheaths, used for the assessment of airway walls and peribronchial lymph 
nodes.
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endobronchial ultrasound (eBUS) has revolutionized the field of bronchoscopy because it allows to ob-
serve peribronchial structures and distal peripheral lung 
lesions. The use of EBUS was first described by Hurte 
and Hanrath in 1992.1 EBUS technology exists in two 
forms: radial and convex transducer probes. The radial 
eBUS probe has a 20-mHZ (12-30 mHz available) rotat-
ing transducer that can be inserted together with or with-
out a guide sheath through the working channel (2.0-2.8 
mm) of a standard flexible bronchoscope. The transducer 
rotates and produces a 360-degree circular image around 
the central position of the probe. There are two types of 
radial EBUS probes: “peripheral” probes, used to identify 
parenchymal lung lesions, and “central” probes, with bal-
loon sheaths, used for the assessment of airway walls and 
peribronchial lymph nodes.2
The convex EBUS probe is a flexible bronchoscope 
with a convex ultrasound probe at its tip that enables the 
sampling of lymph nodes adjacent to the airway under 
real-time ultrasound guidance. This eBUS bronchoscope 
has an external diameter of 6.9 mm, larger than a standard 
flexible bronchoscope. Usually, endobronchial examina-
tion is limited because of the restricted and oblique en-
doscopic view, and so a standard bronchoscopy may be 
needed for a complete airway examination. The 5-15 MHz 
EBUS transducer is convex and offers a scanning depth 
of up to 12 cm and a scanning range of 60°. a disposable 
latex balloon can be placed over the transducer and can 
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Tools such as EBUS-STAT (EBUS skill and task assess-
ment tool) and EBUSAT (EBUS skill and assessment tool) 
were effective in evaluating the EBUS trainees.6
In summary, trainees need to know about the following 
subjects:
• anatomy and imaging (cT scan, PeT) of mediastinal 
lymph nodes and correlation with ultrasound bronchos-
copy;
• node landmarks for cTBNA and EBUS-TBNA, as 
well as nodal maps of the International Association for the 
Study of Lung cancer (iaSLc) guidelines and understand 
key anatomical relations at each of the seven commonly 
biopsied sites;
• diagnosis and staging of NScLc and role of eBUS/
TBNa in the staging algorithm;
• organization of endoscopic suite and knowledge of 
the equipment for the performance of eBUS/TBNa on pa-
tient under moderate and deep sedation;
• strategy of systematic approach and selective ap-
proach;
• contraindications and risk/benefit ratio of EBUS/
TBNa, eUS-B-TBNa and eUS/TBNa;
• equipment for eBUS/eUS: ultrasound broncho-
scopes, ultrasound machine and different-sized needles;
• physics and principles of ultrasound;
• technique for collecting cytology and histology speci-
mens; types and sizes of needles and guide systems;
• basic knowledge of cytology: technique of rapid staining 
and reading of slides for a rapid on site evaluation (rOSe);
• alternative sampling methods (i.e. mediastinoscopy);
• risk management, informed consent and medical legal 
issues.
Knowledge of anatomy 
of mediastinal lymph nodes
according to the international association for the Study of 
Lung Cancer (IASLC) classification, the hilo-mediastinal 
lymph node are divided into different lymph node regions7 
delimited from specific anatomic borders. It’s essential to 
know these anatomic borders in order exactly individu-
alize the lymph node stations; moreover it’s possible to 
recognize some of this borders with EBUS/EUS-(B) ul-
trasound findings, helping in distinguish one lymph node 
station from the other.
The iaSLc map (Figure 1)7 divides mediastinal lymph 
nodes into 7 zones: supraclavicular, upper, aortopulmo-
nary, subcarinal, lower, hilar, interlobar and peripheral. 
These zones are further classified into 14 numbered sta-
be inflated with normal saline through a special balloon 
channel inside the scope. The echo-bronchoscope has a 
2.0 working channel that allows the entry of the aspiration 
needle. The needle has an internal diameter equivalent to 
21, 22, 25 and 19 G and the depth of penetration can vary 
between 5 and 40 mm with a safety lock. After endobron-
chial intubation, the eBUS-TBNa scope is positioned at 
the approximate location of the target lymph node or para-
tracheal tumor. Simultaneous imaging of the endoscopic 
and ultrasound views, as well as a detailed knowledge of 
mediastinal anatomy facilitate the identification of target 
lesions. Once the target lymph nodes or tumor are identi-
fied, real-time TBNA is performed. Most mediastinal and 
hilar lymph nodes are accessible with EBUS -TBNA bron-
choscope except for the aorto-pulmonary (station 5), sub-
aortic (station 6), paraesophageal (station 8) and pulmo-
nary ligament (station 9) nodes. For mediastinal staging 
of non-small cell lung cancer, three cytology aspirations 
of lymph node stations are recommended, if an adequate 
core specimen is obtained, then two passes will enough.3
Real-time EBUS-TBNA has shown higher diagnostic 
yield in mediastinal staging than blind TBNa. The diag-
nostic sensitivity is 90% and specificity is 100%. Even 
without the presence of rapid on-site cytology, diagnostic 
yields of 88-100% have been reported for real time eBUS-
TBNa. The endoscopic ultrasound (through the esopha-
gus) with fine needle aspiration EUS-FNA, and the trans-
esophageal and gastric use of the eBUS (eUS-B-FNa) 
have been performed in the last decade by pulmonologist 
for the diagnosis and staging of lung cancer and for the 
diagnosis of benign diseases.
EBUS-TBNA with transesophageal EUS-FNA can 
complete staging of mediastinum with access to not ac-
cessible lymph node stations (station 8 and 9). diagnostic 
sensitivities of 93-94% have been reported with EBUS and 
eUS combined procedures.4
Training to perform EBUS includes knowledge of imag-
ine interpretation, knobology (that is the use of ultrasound 
processor), orientation of endoscopic and ultrasound views, 
knowledge of biopsy techniques, thoracic anatomy and ba-
sic competence in flexible bronchoscopy/TBNA.2 The ac-
curacy of EBUS-TBNA depends on experience.5 an eBUS 
simulator accurately stratifies individuals on the level of 
experience in performing EBUS. Training achieved on a 
simulator is comparable to traditional apprentice-based 
training. Importantly, skills acquired on a simulator could 
be transferred to real patients. The number of eBUS need-
ed to overcome the initial learning curve varies from 10 to 
100 in individual studies with a mean of 37-44 procedures. 
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Staging of lung cancer
Lung cancer staging is a crucial step in a patient poten-
tially suitable for surgery. in particular, evaluation of me-
diastinal metastatic spread represents the main prognostic 
factor, when distant metastasis are not present;8, 9 medias-
tinal staging is a primary task of the pulmonologist.
accP Guidelines on diagnosis and management of 
Lung cancer, 3th edition, state that a needle technique 
(endobronchial ultrasound needle aspiration [eBUS-Na], 
endoscopic ultrasound needle aspiration [eUS-Na] or 
combined eBUS/eUS-Na) is recommended over surgical 
staging as a best first test in patients with high suspicion of 
N2, N3 involvement either by discrete mediastinal lymph 
node enlargement or PET uptake, when adequate technolo-
gy and appropriate experience and skill of the operators are 
available and no distant metastases are present. moreover, 
a needle technique is suggested in patients with intermedi-
ate suspicion of N2-N3 involvement, i.e. patients with nor-
mal mediastinum by cT and PeT and central tumor or N1 
lymph node enlargement;10, 11 in the latter case, the preva-
lence of mediastinal involvement was demonstrated to be 
relevant (up to 23.5%),12 whereas the indication to invasive 
mediastinal staging after negative Tc and PeT in case of 
central tumors is based on a unique multicenter study that 
does not separate cN1 from central tumors.13 Likewise, no 
distinction is made by guidelines either on the basis of tu-
mor histology (squamous vs. adenocarcinoma) or of pleu-
ral contact/invasion; most literature contributions report a 
higher mediastinal involvement rate in adenocarcinoma 
than in squamous cell carcinoma,14-17 and in the event of 
adenocarcinoma with visceral pleural invasion (fissures 
included).18-20 These factors should be taken into account 
when deciding on endosonographic staging approach.
even for peripheral tumours >3 cm (especially adeno-
carcinoma with high FDG uptake) and, by some authors, 
for those with low maximum standard uptake value,9, 21 
further mediastinal staging techniques providing histol-
ogy should be considered. Whilst many evidences sup-
port the relationship between a high FDG uptake in the 
primary tumor and the risk of lymphatic or distant meta-
static spread,12, 22 the risk of occult mediastinal metastasis 
in case of low SUV value is less convincing or even con-
tradicted by recent works.23
Several meta-analyses on eUS-FNa alone, eBUS-TB-
Na alone, and combined eUS+eBUS reported a pooled 
sensitivity of 83% to 94% for mediastinal staging of lung 
cancer.24-30 Only one randomized controlled trial31 has 
been performed, comparing the two staging strategies pro-
posed in the eSTS 2007 guidelines (either mediastinos-
tions with the descriptor R or L added to denote laterality 
(r, right; L, left).
To adequately perform, it is mandatory to have a pro-
found knowledge of mediastinal anatomy and be able to 
correlate it to the ultrasound landmarks (both EBUS and 
EUS) and the endobronchial specific puncture site.
Knowledges of diseases
Indications to the procedure
• Staging of non-small-cell lung cancer (NScLc) ac-
cording to american college of chest Physicians (accP) 
guidelines;
• restaging after neoadjuvant treatment;
• diagnosis of mediastinal/hilar nodes in patients with 
lung masses, either as the first means of making a tissue 
diagnosis or as the means of staging a known cancer;
• diagnosis of other isolated mediastinal masses;
• confirmation of sarcoidosis in patients with bilateral 
mediastinal/hilar nodes, either as a sole method or in com-
bination with transbronchial lung biopsy;
• tumor near esophagus and tracheobronchial tree.
Figure 1.—iaSLc map.
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These conflicting data require further confirmation with 
controlled, prospective trials; in the meanwhile, much pru-
dence has to be used when evaluating these results, since 
many procedural limitation could influence their value.
Mediastinal masses and granulomatosis
Benign or malignant mediastinal masses can develop from 
structures that are normally located in the mediastinum, as 
well as from metastases of malignancies that arise from 
the lungs, or from other parts of the body.
Mediastinal masses can be an incidental finding in pa-
tients who undergo chest radiography or more advanced 
imaging studies, e.g. computed tomography (cT) or mag-
netic resonance imaging for other reasons. These investi-
gations may have been obtained prior to elective surgery, 
e.g. in case of lung cancer, or as part of the evaluation of 
an unrelated condition. However, more frequently medi-
astinal masses are symptomatic, in these cases due to ma-
lignant lesions. Symptoms, when present, may be caused 
by the direct mass effect of the mediastinal abnormalities, 
or systemic effects of the illness, e.g. fever, night sweats, 
and weight loss can be present in the case of lymphoma, or 
may be due to a variety of paraneoplastic syndromes, such 
as myasthenia gravis with thymoma. Direct involvement 
or compression of normal mediastinal structures cause a 
wide range of symptoms, e.g. cough, stridor, hemoptysis, 
shortness of breath, pain, dysphagia, hoarseness, facial 
and/or upper extremity swelling due to vascular compres-
sion (e.g. superior vena cava syndrome), hypotension due 
to tamponade physiology or cardiac compression, and 
Horner syndrome due to sympathetic chain involvement. 
in the suspicion of a mediastinal mass, diagnostic evalu-
ation includes history and physical examination, supple-
mented by laboratory and imaging studies. Laboratory 
studies or blood tumor markers might support a specific 
diagnosis. concerning imaging, the location of the mass 
often helps narrowing the differential diagnosis. As an ex-
ample, the presence of a large anterior mediastinal mass 
and elevations in certain tumor markers might establish 
the diagnosis of some germ cell tumors. in other cases, 
a tissue biopsy (percutaneous, endobronchial, or surgical) 
may be necessary to confirm a clinical suspicion prior to 
establishing a therapeutic plan.
CT of the chest with intravenous contrast is typically 
used to evaluate abnormalities seen on chest radiographs. 
chest cT also provides detailed information regarding 
the mediastinal abnormality, including its location, size, 
relationship to other structures, and tissue characteris-
tics, including presence of fat, fluid, or calcifications (e.g. 
copy, or alternatively endosonography followed by me-
diastinoscopy).9 There was no difference in sensitivity or 
NPV when compared with endoscopic staging. However, 
the staging strategy starting with combined endosonog-
raphy and if negative combining it with surgical staging 
has proven to detect significantly more mediastinal nodal 
N2/N3 disease compared to mediastinoscopy alone.32 This 
strategy has been recently debated; on the basis of the 
current guidelines, a surgical confirmatory staging proce-
dure should be chosen when the risk of N2-N3 metastasis 
is considered still high even after a negative cytological 
result.10 The significance of “residual high suspicion” is 
not clearly specified, however it seems reasonable that for 
example in case of high FDG PET uptake, a subsequent 
negative cytology should prompt a surgical confirmation.
Some authors speculate that omitting mediastinoscopy 
after negative endosonography in mediastinal staging of 
NScLc does not result in an unacceptable percentage of 
unforeseen N2 disease at surgical resection;33 omitting 
mediastinoscopy comprises no extra waiting time, omits 
one extra general anesthesia and hospital admission, and 
may reduce morbidity and costs, with comparable sur-
vival. However, the decision to avoid a surgical confir-
mation after a negative cytology from endobronchial or 
endoesophageal needle aspiration should take into consid-
eration the residual probability of mediastinal metastasis 
after a negative cytology, and suggest direct resort to sur-
gery only when the final probability is below a predefinite 
threshold; a mathematical model based upon Bayes’ theo-
rem was proposed by some authors to get an estimation of 
the residual probability of mediastinal involvement after 
every staging procedure.34
There is evidence coming from prospective studies 
performed in experienced endosonography centers, that 
EBUS keeps a high sensitivity and concurrently medias-
tinoscopy may not improve diagnostic yield after a well-
performed negative endosonography with needle aspira-
tion of at least three mediastinal nodal stations in patients 
with low (<35%) prevalence of mediastinal disease.2, 35, 36 
However, in a discordant manner, data from one prospec-
tive study published in 2010,37 3 recent studies38-40 among 
which two retrospective and one prospective, and a meta-
analisis41 report a low sensitivity in mediastinal staging 
(respectively 68% and 35-49%) in cN0-1 patients with 
negative mediastinum after Tc and PeT, hence, precisely 
in case of low prevalence of mediastinal metastasis. Based 
on these observations, some authors40 question whether 
EBUS is the best choice in patients with resectable cN1 
(but also cN0) lung cancer.
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lesions (other than NScLc). The most common use for 
convex probe EBUS-TBNA in this setting is in patients 
with bilateral hilar adenopathy to distinguish sarcoidosis 
from lymphoma. although eBUS has been established 
as an effective modality to diagnose lung cancer, its sen-
sitivity for the diagnosis of lymphoma has been demon-
strated to be lower. Because of this lower yield, uncer-
tainty persists about the ability of eBUS-TBNa to reli-
ably diagnose lymphoma and questions remain regarding 
the utility of EBUS-TBNA as a first-line biopsy modality 
for patients suspected of having lymphoma. However, 
some recent data seem to be promising. in a recent report, 
although the number of patients affected by lymphoma 
was relatively low (17 patients), the authors showed 
an overall sensitivity of eBUS-TBNa for lymphoma 
of 85%, together with an adequate subtyping, allowing 
treatment recommendations.46 Frequently, with the cur-
rent 21- and 22-gauge (G) eBUS-TBNa needles, the 
procedure might be limited by the degree of flexibility in 
the needle and the size of the lumen in tissue acquisition. 
Recent data with a first-generation flexible 19-G EBUS-
TBNa needle suggest a successful diagnostic yield also 
in cases of lymphoma (100%),47 although the number of 
lymphoma was small (4 cases). When lymphoma is high-
ly suspected and endobronchial biopsy is not possible or 
cannot provide adequate tissue to definitively establish a 
diagnosis, surgical biopsy may be necessary, excisional 
biopsy of a small mass, if possible, or incisional biopsy 
of a large mass is preferred, although in select cases large 
core needle biopsies may be adequate.
in cases of granulomatous diseases, e.g. sarcoidosis (and 
tuberculosis), several studies have reported a high diagnos-
tic yield of eBUS-TBNa for the diagnosis of sarcoidosis, 
with a diagnostic yield of EBUS-TBNA of 83.3% (higher 
than TBNA 53.8%, P<0.05), a pooled diagnostic accuracy 
of 79% (95% CI 71% to 86%) in a systematic review and 
meta-analysis, whereas the clinical factors associated with 
successful demonstration of non-necrotizing granuloma-
tous inflammation in EBUS-TBNA samples have not been 
clearly established.48-50
concerning eUS-FNa in the diagnosis of sarcoidosis, 
a study from 101 consecutive patients (55% of whom 
had previously had a non-diagnostic bronchoscopy) with 
suspected pulmonary sarcoidosis (stage I and II), who 
underwent EUS-FNA of mediastinal lymph nodes with 
22-gauge needles showed that the sensitivity of EUS in 
detecting granulomas was 87% (cytology and cell-block 
analysis together) (stage i, 92%; stage ii, 77%). in 33% of 
cytology negative patients (N.=6), granulomas were pres-
teratoma). Such detailed information, particularly the in-
volvement or compression of surrounding structures, is 
important in the treatment approach. When lymphoma 
is suspected, positron emission tomography (PeT) using 
18F-fluorodeoxyglucose (FDG) with fused CT may be 
performed, being useful to identify a preferred biopsy site. 
it must be highlighted that also non-malignant conditions, 
such as teratoma and thymic cysts, have shown to have 
FdG accumulation in 14% to 42% of cases.42-44
The mediastinum is divided into main three compart-
ments, and this is useful in developing a differential diag-
nosis when an abnormality is detected: the anterior, middle 
and posterior compartment. The most common lesions oc-
curring in the anterior mediastinum are represented by thy-
moma, teratoma/germ cell tumor, lymphoma, and thyroid 
tissue, whereas in the middle mediastinum is lymphade-
nopathy, which can be secondary to lymphoma, sarcoid, or 
metastatic lung cancer. Neurogenic tumors represent the 
majority of posterior mediastinal masses.
EBUS and/or EUS are reasonable to consider when the 
mediastinal mass is located mainly in the middle (and pos-
terior) mediastinum, immediately adjacent to an airway 
or to the esophagus. Lesions in these locations are often 
difficult to access percutaneously even with radiographic 
imaging guidance due to the proximity of major vascular 
structures. There are rather limited data as to the use of 
eUS-FNa in the diagnosis of mediastinal lymphoprolifer-
ative disorders, showing a good sensitivity and specificity, 
although lower as compared to NSCLC. The combination 
of EUS-guided FNA±flow cytometry (FC) for the diag-
nosis of lymphomas was initially considered controver-
sial, but some retrospective data showed that EUS-FNA is 
sensitive and specific for the diagnosis of suspected lym-
phoma. Confirmatory further testing should be performed 
when EUS-FNA with or without FC is indeterminate and 
or non-diagnostic. The overall sensitivity and specificity 
in the diagnosis of lymphoma is 73 to 87%, 87 to 100%, 
with a positive predictive value, negative predictive value 
and accuracy of 97%, 60% to 75% and 83% to 89%, re-
spectively.45, 46
For mediastinal masses/lymphadenopathy of unknown 
origin, the european Society of Gastrointestinal endosco-
py (eSGe) recommends performing eUS-guided (or alter-
natively eBUS-guided) sampling if the pathological result 
is likely to affect patient management, and no superficial 
lymphadenopathy is easily accessible, with strong recom-
mendation, moderate quality evidence.45
eBUS can visualize and sample mediastinal and hilar 
lymphadenopathy to distinguish benign from malignant 
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• velocity of blood=Wavelength (mm) x frequency 
(Hz);
• wavelength (mm)=1,540,000 mm/sec ÷ frequency 
(Hz);
• wavelength (mm)=1,54 ÷ frequency (MHz).
The resolution of a recording, ie, the ability to distin-
guish two objects that are spatially close together, varies 
directly with the frequency and inversely with the wave-
length. High frequency, short wavelength ultrasound can 
separate objects that are less than 1 mm apart (Figure 2).
Imaging with higher frequency (and lower wave-
length) transducers permits enhanced spatial resolution. 
However, because of attenuation, the depth of tissue pen-
etration or the ability to transmit sufficient ultrasonic en-
ergy into the chest is directly related to wavelength and 
therefore inversely related to transducer frequency. as a 
result, the use of higher frequency transducers reduces 
tissue penetration.
The trade-off between tissue resolution and penetration 
guides the choice of transducer frequency for clinical im-
aging.
Propagation, reflection, refraction and attenuation
Propagation is the process in which sound advances 
through various substances such as air and water.
The transducer serves as both the source and sensor of 
a pulsed signal; the signal is sent out, penetrates tissue and 
is then reflected back to transducer. The intensity of re-
flection is higher wherever there is a significant change 
in the propagation medium. The degree of reflection is 
determined by the acoustic impedance of the adjacent tis-
sue. Acoustic impedance (Z=density x speed of sound) is 
related to tissue density.
When the US beam strikes an interface, it undergoes 
refraction, scattering and attenuation.
ent in the cell block. The optimal yield for granuloma de-
tection was reached with four needle passes. One patient 
developed mediastinitis after eUS-FNa.51
Knowledge of basis of sonography 
and of the instruments
Basis of sonography
eBUS is a bronchoscopic technique that uses ultrasound 
to visualize structures within and around the airway wall 
as well as the lung.
Sound waves are mechanical vibrations that can be de-
scribed in terms of frequency or Hertz (Hz), i.e., the num-
ber of repetitions or cycles per second.
The sounds heard by humans are between 16 Hz and 20 
KHz. Waves with frequencies above, we define ULTRA-
SOUNd.
Medical ultrasound imaging typically uses sound waves 
at frequencies of 1,000,000 to 20,000,000 Hz (1.0 to 20 
mHz).
The ultrasound beam is composed of a train of waves 
generated by piezoelectric effect by a sensor or transducer. 
To this effect, the electrical energy is converted into me-
chanical energy and vice versa vibratory.
ECO is an acoustic phenomenon that occurs when a 
sound meets a “wall” that reflects it; the echo is reflected 
sound.
Echogenicity represents the extent to which a structure 
(tissue or substance) gives rise to reflections of ultrasonic 
waves. When US images are displayed on a grey scale, 
the strongest echo signal is white. When no sound wave 
is reflected, the image is black, or, in US terms, anechoic.
Frequency represents a specific number of vibration 
cycles per second, measured in units of hertz. eBUS fre-
quencies range from 5 to 12 MHz. Dedicated convex-probe 
EBUS-TBNA bronchoscopes allow a change in frequency 
from 5 to 12 MHz, while available high-frequency radial 
eBUS systems use frequencies of 20-30 mHz.
An US wavelength represents the distance between two 
successive pulses: the higher the frequency, the shorter the 
related wavelength. Transducers may serve as both source 
and sensor of the acoustic signal: they convert electrical 
signals to US waves and transmit them, and pick up the 
reflected waves and convert them into electrical signals.
Frequency and wavelength are mathematically related 
to the velocity of the ultrasound beam within the tissue 
(approximately 1,540,000 mm/sec for human tissue) as in-
dicated by the following equations:
Figure 2.—Ultrasound absorption. High frequency corresponds to a low 
depth for effect of absorption.
absorption
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depth
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Ultrasound imaging
Ultrasound waves are produced by a transducer, a device 
that use piezoelectric crystals to both generate and receive 
ultrasound waves. The transducer converts electrical sig-
nals to US waves, pick up the reflected waves and converts 
them in electrical signals. The electrical signals returned 
from the transducer form an image on a display panel. ce-
ramics such as lead-zicornate titanate are commonly used 
transducers materials.
The crystals deform and vibrate when electronically 
stimulated to produce acoustic pulses. When echoes return 
to the transducer distort the crystals and produce an elec-
tric pulse that is processed into an image (Figure 5).
Instruments (Transducers and scanning methods)
EBUS
There are two types of Ultrasound transducers used in 
bronchoscopy:
• 20 and 30 mHz miniaturized radial transducers that 
refraction represents a change in direction of the inci-
dent US beam. Scattering is the spread of the US in dif-
ferent directions. attenuation is loss of energy caused by 
absorption (Figure 3).
Image artefacts
We have reverberation artefacts when a highly reflective 
tissue is parallel to the transducer, or when the balloon of 
the EBUS probe is not in perfect contact with the airway 
wall and the acoustic waves are repeatedly reflected be-
tween the airway wall and the transducer. False echoes 
appear as multiple equally spaced lines on the US image.
In addition to intimate contact between the transducer 
and the airway wall, image quality adjustments are made 
using gain, contrast and doppler functions on the processor.
Gain, Doppler, Color Doppler
Gain represents the function for adjusting the brightness of 
the image. When the US waves travel into the tissue, high 
frequencies components are absorbed more than low fre-
quencies; the loss of amplitude is corrected by amplifying 
the signal proportional to the depth from which the echo 
comes. The amplifier is controlled by the operator.
The doppler effect represents the phenomenon through 
the frequency of the reflected ultrasound wave is changed 
when it strikes a moving object (i.e. blood cells within 
blood vessels).
color doppler refers to a color code used to indicate 
flow direction and velocity.
By convention, the flows approaching the transducer are 
represented in RED, those moving away in BLUE (Figure 
4). in general, the doppler angle needs to be 60° or slightly 
less compared to the long axis of the vessel to obtain the 
right velocity. if the US scanning plane is perpendicular to 
the direction of blood flow, it is possible that there will be 
no doppler signal.
Figure 3.—Principles of ultrasound.
Figure 4.—modes of ultrasound in medicine.
Figure 5.—Piezoelectric effect.
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tal extremity. The optical visual field of view is 80-100° 
and the direction of the white-light viewing axis is 10-45° 
forward oblique, depending on the type of the broncho-
scope used (Table I). The working channel is between 2.0- 
2.2 mm (Figure 6, 7, 8). The EBUS TBNA needles exit 
from the insertion tube at 20° angle. To date, a new EBUS 
is available: it is the eBUS Olympus BF-Uc190F.
There are various commercially available eBUS – 
TBNa needles: 21, 22 and 25 gauge has been developed 
for tissue sampling. New EBUS-TBNA needles 19 gauge 
have recently been introduced; they are more flexible and 
seem to allow easier access to the most difficult lymph 
node stations.
We have first evaluations on numerically limited cases. 
real effectiveness requires more studies.
EUS
Similarly to EBUS, EUS is performed with a “dedicated” 
echoendoscope, allowing real-time visualization of FNa, 
usually used in the past by gastroenterologists and cardiol-
ogists. different linear eUS scopes are available, present-
ing with an oblique viewing direction of 40°, a scanning 
range of 100° to 180°, a frequency range of 5-12 mHz, 
a 3.7-3.8 mm diameter integrated working channel with 
elevator, a bending capability of up/down (130-160°/90-
160°) and left/right (90°-120°/90°-120°), all incorporating 
color and power Doppler. 
EUS-B-FNA
In the last few years EBUS has disseminated from aca-
demic centers to community-based hospitals and is now an 
important equipment in most bronchoscopy unit while the 
eUS is not so diffused in the bronchoscopy unit. Gradually 
more chest physicians are also inserting the eBUS scope 
into the esophagus due to its advantage and encouraged by 
their familiarity with the equipment.
The eUS-B-FNa consists in the mediastinal lymph 
node evaluation and sampling by the introduction of an 
eBUS bronchoscope into the esophagus instead of into 
the airways. Differently from EUS, for EUS-B, the flex-
ible eBUS endoscope is inserted and advanced through 
the esophagus with the patient lying in the supine posi-
tion (and not lying on the left side as for the eUS proce-
dure). eUS-B- FNa might increase the diagnostic utility 
of eBUS-TBNa by further coverage of mediastinal LN 
stations and access to subdiaphragmatic site lesions.
The integration of the two techniques, EBUS-TBNA 
and EUS-FNA (EUS-B-FNA), significantly improves sen-
provide a 360° scanning plane that is perpendicular to the 
probe axis;
• Convex linear probe.
The Convex-probe linear array (Table I) is comprised of 
a group of adjacent elements arranged in linear sequence 
on the transducer. The probe is positioned on the tip of the 
bronchoscope.
The elements are electrically phased to produce a beams 
that sweep a 2D plane in the shape of hand-fan or pie-slice 
(50-60°), parallel to the axis of the bronchoscope; the elec-
tronic beam is focused at selected depth.
The convex probes commercially available have fre-
quency between 5 and 12 MHz.
The outer diameter of the scopes have 6.9-7.45 mm dis-
Figure 8.—eB530US.
Table I.— Technical characteristics of the different EBUS endo-
scope.
model Pentax  eB19-J10U
Fuji  
eB530US
Olympus  
BF-Uc190F
direction  
of viewing field
Forward 
oblique [45°]
Forward 
oblique [10°]
Forward 
oblique [20°]
Field of view [°] 100 120 80
Depth of field [mm] 2-50 3-100 2-50
Tip deflection ud/down [°] 120/90 130/90 160/70
insertion tube [Ø mm] 6.3 6.3 6.3
distal end [Ø mm] 7.3 6.7 6.6
instrument channel [Ø 
mm]
2.2 2.0 2.2
Working length [Ø mm] 600 610 600
Scanning angle  [°] 75 65 65
acustic frequency [mHz] 5, 6.5, 7.5, 10, 
13 switchable
5, 7.5, 10, 12 5, 6, 7.5, 10, 
12
Scanning direction Parallel Longitudinal Parallel
Scanning system Convex Convex Convex
Figure 6.—Olympus 
BF-Uc190F.
Figure 7.—Pentax EB19-J10U.
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on blind TBNA technique (minimum 100 flexible bron-
choscopy and 5 TBNa).
• active participation in the multidisciplinary team with 
radiologists, pathologists, oncologists, thoracic surgeons;
• decision on systematic versus selective approach;
• sedation and oxygenation techniques, and manage-
ment of related complications;
• clinical and radiographic (cT scan and PeT) evalu-
ation of the patient and her/his comorbidities; risk evalu-
ation and management of difficulties and complications;
• radiographic/endoscopic correlations;
• competent use of ultrasound device;
• endoscopic finding of the landmarks of tracheobron-
chial node stations;
• ability to visualize with EBUS mediastinal lymph 
nodes and vessels and their anatomic relationship;
• competent use of different sizes and types of needles 
and other accessories (balloons) and ability to pass TBNa 
needle through wall of trachea/bronchus into node;
• management of the needle specimens;
• interpretation and reporting of test findings: size, shape, 
margins, echogenicity, presence of internal hypoechoic 
zones due to the presence of necrosis, elastography;
• prevention and management of procedure-related 
complications.
Procedural steps
although a huge amount of literature has been produced 
since its introduction, most studies have been devoted to 
the description of the performance characteristics associ-
ated with EBUS-TBNA, whereas papers describing the 
technical aspects of the procedures are quite scant. rela-
tively recently, however, the World Association for Bron-
chology and interventional Pulmonology (WaBiP) and 
the american college of chest Physician (accP) have 
published guidelines aimed at describing the evidence be-
hind the many practical aspects of eBUS-TBNa.53, 54
Sedation
adequate sedation is an important part of the procedure 
since it provides patient’s comfort and potentially in-
creases diagnostic yield. A recent systematic review of the 
literature (6 studies, 3000 patients) found out that using 
moderate sedation in eBUS-TBNa has comparable diag-
nostic yield and safety profile to deep sedation.55 However, 
the authors conclude that the decision on the method of 
sedation for eBUS-TBNa should be individually selected 
based on operator experience, patient preference, as well 
sitivity in detecting mediastinal nodal metastases, reduc-
ing the need for surgical staging procedures. international 
guidelines recommend at present endosonography with 
fine- needle aspiration as first diagnostic step for medias-
tinal nodal staging in non-small-cell lung cancer and com-
bined endosonographic procedures are now the new gold 
standard when performed by an experienced operator.
compared to eBUS-TBNa, eUS-FNa and eUS-B_
FNA have the advantage of being comparably well tolerat-
ed with lower doses of anaesthetics and sedatives, shorter 
procedure time, less oxygen desaturation, less coughing; 
further, it offers greater scanning angles (150-180° as 
against 50-60°), better imaging with a higher resolution 
and better visualization of very small structures, with the 
transducer in close contact with the target, enabling de-
sufflation to make the lumen virtual, with no interposed 
cartilage between needle and target; the presence of the 
elevator makes the needle more maneuverable, including 
the option of using 19G needles.
It is essential to willfully understand the ultrasound 
anatomy and landmarks of the esophageal approach con-
sidering that there are not endoluminal references for a 
specific puncture site with this kind of approach. With 
EUS or EUS-B we can visualize and sample the regions 
not reachable with the endobronchial approach as the sta-
tion 8, 9 the adrenal gland and sometimes the 5 (if consid-
erable enlarged). The para-aortal lymph nodes (station 6) 
are even more difficult to assess; biopsy (from above the 
aortic arch) is often difficult avoiding the large mediastinal 
vessels, and the transaortic approach using a 25G-needle 
may be used only in selected cases.52
But using the esophageal ultrasound is often easy to 
sample stations reachable also with EBUS as the 4L 7. In 
coughing patients, getting a good sample out of a small 
lymph 4L with EBUS can be troublesome; in this case it is 
useful switch to EUS-B and puncture without cough and 
without cartilage rings.
It is important to keep in mind that through the esopha-
gus approach it is difficult to visualize the sheet consider-
ing that it is a virtual lumen. The operator must be sure that 
the sheet is out indirectly visualizing a lack of echographic 
signal in the point where the sheet push on the esophageal 
wall not allowing the contact of the us probe in that precise 
point.
Core basic skills
• The first prerequisite for learning ecoendoscopy is to 
have a strong competence on flexible bronchoscopy and 
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Use of the scope
A range of instruments with linear transducers suitable are 
available and one of the most evident differences between 
those and the normal scope is the angle of vision that can 
vary from 10° to 45°.63
The operator has to be trained to use the scope in a dif-
ferent way comparing to videobroncoscope. In fact to ob-
tain a straight view the bronchoscope needs to be slightly 
flexed down, while to advance the operator should return to 
the neutral position in order to avoid the trauma of the tra-
cheobronchial wall. It can be useful to alternate the straight 
view (with the scope flex down) to know the scope’s posi-
tion, and the angle view to advance within the airway.62
EBUS is usually inserted orally into the trachea, but few 
physicians use the nose approach when it’s possible, even 
if there are no evidence to recommend this approach.
Once the operator has identified the larynx, he/she can 
advance and pass through the vocal cords visualizing the 
anterior angle of the glottis because of the angle of view. 
do not force the scope into the glottis, because the tip is 
not visible and may cause dislocation of the cartilage.62 it 
is important to know how to manage the scope and all the 
instruments in order to reach a good aspirate and avoid the 
damage of the bronchoscope.
The eBUS scope could be inserted into the esophaghous 
for a EUS-B procedure. In this case the scope must be flex 
down when the larynx is visualised, and slightly advanced 
behind the posterior region of the larynx, looking for the 
superior esophageal sphincter. You can ask to the patient 
to swallow while you gently try to insert the scope; in case 
of resistance do not force the scope and use some water 
to hydrate. Similarly to EBUS, EUS is performed with a 
“dedicated” echoendoscope. Procedure is performed with 
the patient lying on his/her left side, and it begins once the 
patient is adequately sedated, either under mild sedation 
with midazolam, or under deep sedation with anesthesia 
care, based on the internal structure organization. The in-
strument is introduced through the mouth (through the use 
of a mouthpiece), and gently pushed until the gastric wall. 
From here the operator should know how recognize ana-
tomical structures on ultrasound in order to find the regions 
of interest. Through the introduction of a 22 gauge needle 
(also available 19,21 and 15 gauge needles) in the operat-
ing channel of the echoendoscope, eUS-FNa can be per-
formed under real-time ultrasound guidance. The risk of 
infection or bleeding is negligible, complications are rare, 
and no mortality has been reported. EUS-FNA allows easy 
access to the subcarinal region 7, to the left paratracheal 
as duration of the anticipated procedure. This is probably 
related to the fact that most studies that assessed the role 
of sedation in the setting of EBUS-TBNA were observa-
tional and retrospective, and they come to different con-
clusions.5, 55-60
in one of the largest observational trials, for instance, 
Yarmus et al. analyzed a cohort of 309 patients who un-
derwent EBUS-TBNA in two US centers, and concluded 
that deep sedation improves diagnostic yield and allows 
to sample more lymph node stations. Several other obser-
vational trials tend to contradict these findings and sug-
gest that both diagnostic yield and complication rate are 
not different in patients submitted to eBUS-TBNa under 
moderate or deep sedation.56
in the only randomized controlled trial currently avail-
able, 149 patients underwent EBUS-TBNA with either 
moderate or deep sedation in a single institution and by 
a single experienced operator.61 No difference was found 
in diagnostic yield, but fewer patients in the moderate se-
dation group completed the procedure (P=0.28) and few-
er patients in the deep sedation group (5.3% vs. 29.6%, 
P<0.001) experienced anesthesia-related complications 
(i.e. arrhythmias, hypoxemia, hypotension, hypertension, 
etc.).
Based on these data, both the WaBiP and the accP 
guidelines conclude that either moderate or deep seda-
tion are acceptable approaches for eBUS-TBNa, but un-
derline that this conclusion should be taken with caution 
owing to the inherent limitations (low quality, limited 
size, level of evidence) of the studies that analyzed this 
topic.
in case of moderate sedation, in an ambulatory set-
ting for moderate conscious sedation midazolam (Versed; 
Roche Pharmaceuticals, Nutley, NJ, USA) with or without 
Fentanyl (Fentanyl Citrate Injection; Baxter, Deerfield, IL 
USa) are given intravenously before the start of the proce-
dure. A local anesthesia with lidocaine is applied on larynx 
some minute before the bronchoscope is inserted orally. 
Lidocain is also sprayed on larynx and airway through the 
instrument channel. Electrocardiogram, pulse oximetry, 
and blood pressure should be monitored during the pro-
cedure.62
in case of general anesthesia, endotracheal tube, rigid 
bronchoscopy or laryngeal mask can be used. Cough re-
flex is minimize, so the operator could better perform the 
procedure.
Both the endotracheal tube or the rigid bronchoscope 
should be higher endotracheal placed if a sample of the 
upper paratracheal nodes is required.62
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marks and mediastinal vessels identifiable on ultrasound 
image.
These landmarks are even more important for the esoph-
ageal approach considering that, in this case, no endoscop-
ic reference sites of puncture are present. eBUS and eUS 
landmarks are therefore described, and the knowledge of 
these are fundamental for the echoendoscopic best prac-
tice.52
The US processor has adjustable depth (2-9 cm), gain 
and frequency (range: 5 and 10 mHz;). it also has doppler 
capabilities to identify blood flow in vessels, distinguish-
ing them from lymph nodes.63, 64 Together with elastogra-
phy and the echographic characteristics the doppler also 
allows to better define the characteristics of each lymph 
node, helping in distinguish among benign and malignant 
nodes.
it is recommended to use 7.5 mHz of frequency a 4 cm 
of depth as a routine.63 it could be useful to adjust these 
parameters on the basis of how much superficial the region 
of interest is. In case of superficial and small node (i.e. 7 
mm), it is better to use an higher frequency, a small depth 
and adjust the focus on the region of interest
At the contrary for big and/or deep lesions use a lower 
frequency and a big depth could be helpful to obtain a bet-
ter characterization of the region of interest.
moreover, is possible to measure the dimension of the 
lesions comparing them with the CT scan images and bet-
ter evaluate the need of a sampling.
For all these reasons having a good background of ul-
trasound competence before to performing echoendoscopy 
is imperative.
Needle aspiration
The management of the dedicated needle is one of the 
most specific competence for EBUS so the assistant and 
the operator should know well the needle characteristics.
Before inserting the needle in the channel of the bron-
choscope the proper setting of the needle should be veri-
fied with a double check (operator-assistant): The sheath 
and the needle adjuster knob should be pulled up com-
pletely and locked in order to secure the entire needle into 
the sheath and the sheath into the operating channel of the 
scope.62
The internal stylet should be completely inside the nee-
dle channel.
The EBUS-TBNA needle is fastened into the working 
channel of the bronchoscope with the scope in neutral po-
sition with the tip of the bronchoscope not flexed other-
wise it’s possible to damage the EBUS scope. During this 
region (4L), and partially to the left hilar region (10L). it 
also allows evaluation of the lower mediastinum including 
paraesophageal region 8, and pulmonary ligament region 
9. detection of region 5 is also possible if lymph nodes 
are considerably enlarged, whereas in small lymph nodes 
EUS-FNA might be more difficult or impossible into this 
region, due to interposition of the pulmonary artery/aorta. 
The para-aortal lymph nodes (station 6) are even more dif-
ficult to sample, due to the proximity of the large medias-
tinal vessels. Due to the anatomy of the esophagus, which 
is located behind and to the left of the trachea, eUS-FNa 
is not recommended for the right-sided paratracheal and 
hilar located LN (2r, 4r, 10r), since their visualization is 
prevented by the air contained in the trachea, nevertheless 
is possible sometimes to individuate this station and the 
azygos vein. importantly, eUS-FNa is also capable of de-
tecting metastatic disease in subdiaphragmatic sites, such 
as the left adrenal gland, celiac lymph nodes, and the left 
lobe of the liver.
Visualization of lymph nodes
Once the bronchoscope is introduced into the airway a so-
nographic mapping of the nodal and vascular structures 
of the mediastinum should be performed, and after that 
the target regions are selected, based on a predetermined 
strategy.7
To adequately perform this procedure a perfect knowl-
edge of the mediastinal anatomy on cT scan is mandatory, 
considering the specific lymph node stations according to 
the new International Association for the Study of Lung 
cancer (iaScL) lymph node map;52 and be able to corre-
late it to the ultrasound landmarks (both EBUS and EUS) 
and the endobronchial specific puncture site.62
The endoscopic image and the corresponding ultra-
sound one can be visualized simultaneously on two differ-
ent displays or on a two-screen display.
By flexing up the scope, the tip can have contact with 
the trachea/bronchial wall and the region of interest can be 
visualized. Try to reach every target with slow movement 
of the scope in each region of interest in order to have an 
accurate overview of every zone.62
If the ultrasound imaging is not optimal, a latex balloon 
should be attached to the tip of the EBUS and inflated with 
normal saline. Only 0.3 to 0.5 mL of saline is necessary to 
inflate the balloon during the procedure.62
In the EBUS approach a well-described endobronchial 
landmark is helpful to find the site of sampling of each 
node’s sta tion. The lymph node stations can be recognized 
both with EBUS and EUS-(B), through anatomic land-
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without suction. There is no evidence to recommend one 
specific procedure. For big lymph node or if the ultrasono-
graphic image of the node shows an high vascularization 
of it (using color-doppler) the operator can take the sample 
without suction. If the material achieved is not enough it 
is suggested to apply suction for the following punctures.
On the contrary when the node to sample is little it could 
be useful to start with suction because the movement of the 
needle inside the node will be limited. If significant blood 
contamination is seen within the aspirated material or at 
ROSE, it’s suggested to not use suction for the following 
punctures in order to obtain a better quality sample.
if suction is applied, the internal stylet is removed and 
the syringe is applied on top of the needle. The negative 
pressure is applied when the needle is inside the lymph 
node. EBUS-TBNA may be performed without suction; 
slow pulling the internal stylet in order to create a little 
negative pressure inside the needle.62
The needle is moved back and forth within the lymph 
node (10-20 times). Pull the needle back into the outer 
sheath until you hear the click on the needle. Lock the 
needle and pull the outer sheath back into the channel of 
the bronchoscope. retrieve the needle for collection of the 
specimen.62
in the absence of rapid on-site evaluation (rOSe) in 
patients suspected of having lung cancer and undergoing 
eBUS-TBNa for diagnosis, it is important to perform a 
minimum of 3 separate needle passes per sampling site; 4 
needle passes should be obtained from the target whenever 
molecular testing is planned.54
EBUS-TBNA can be performed with a wide array of 
needles of different size (25-gauge, 22-gauge, 21-gauge, 
and 19-gauge) and materials (nitinol, stainless steel).
Based on these evidences, both the international guide-
lines suggest that there is currently insufficient evidence to 
recommend a specific needle size or type.
Evidence	 regarding	 the	 key	 technical	 aspects	 of	 EBUS-
TBNA
Number of needle passes
a limited number of studies assessed the number of needle 
passes (number of aspirates per lymph node) needed to op-
timize the diagnostic yield of EBUS-TBNA in patients with 
intrathoracic lymphadenopathy, as well as the number of 
needle passes aimed at achieving a complete genotyping in 
patients with known/suspected advanced lung cancer.3, 65-67
Lee et al. evaluated the number of needle aspirates 
needed to optimize specimen’s adequacy and diagnos-
procedure the operator will lose the echographic view of 
the region of interest that later can search again.
Once the needle is locked to the EBUS scope, the sheath 
is advanced out of the end of the scope until it can be vi-
sualized, then is locked. When the needle is blocked inside 
the scope, sometimes the operator can have some difficul-
ties to find again the perfect echographic view region of 
interest.62 it happen because the tip of the scope become 
stiffer with the needle inside and could not have a perfect 
contact with the mucosa. The same thing can happen if the 
sheath is pushed out too far. in these cases the operator 
should try to pull in the sheath in order to have out of the 
working channel the minimum of it (visualizing only the 
tip of the sheath).
The sheath should be always visible before the needle is 
pushed out as well when the needle is inside the lesion.62
in order to visualize the node on the ultrasound image, 
the tip of the bronchoscope should be flexed up for con-
tact with the trachea/bronchial wall. The sheath should be 
wedged in between the cartilaginous ring, if possible.
After the needle adjuster is unlocked, you can choose to 
relock it at precise distance (so the needle can be pushed 
out maximum until this distance, e.g. 3 cm) or left it free 
allowing the maximum exit of the needle (5 cm).
When the operator pushes the needle out the assistant 
should secure the bronchoscope by the patient’s mouth and 
you should immediately view the needle inside the node. In 
order to facilitate the penetration it is suggested to slightly 
retract the internal stylet. Anyway, during this procedure, 
the operator can lose the ultrasound image because the air-
way may be pushed away from the probe when the needle 
penetrate through the trachea/bronchial wall.62 To avoid 
this, it could be useful to push the needle out with a rapid 
and controlled movement (always with the scope secured at 
the patient’s mouth), moreover the assistant can give a little 
push at the same time the operator pushes the needle out.
in case a cartilage ring is encountered during TBNa, 
the bronchoscope is moved a little bit up or down so that 
the needle will go through the intercartilage space. The 
operator must keep the endoscopic images clear during 
the procedure with a perfect view of the needle inside the 
node in order to avoid puncturing undesirable region.62 af-
ter penetration you should clearly view the needle inside 
the node otherwise you can try to find the exact scan with 
slow and small rotation of the scope. When the needle is 
inside the node, the assistant can use the internal stylet to 
clear out the internal lumen, which may become clogged 
with bronchial cells.
The tissue sampling may be performed either with or 
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Only one randomized controlled trial addressed this 
topic. casal et al. randomized 115 patients towards EBUS-
TBNA with or without suction, and found no differences in 
terms of adequacy (88% vs 88%), overall diagnostic yield 
(36% vs. 34%), diagnostic yield for malignancy (28% vs. 
26%), and sample quality.68 interestingly, concordance 
rate between the two techniques was high, ranging from 
83.3% to 95.8% for adequacy, diagnostic yield and speci-
men quality.68
A few more studies have assessed the impact on differ-
ent levels of pressure suction during eBUS-TBNa.69, 70 
Boonsarngsuk compared EBUS-TBNA with no suction, 
-20 and -40 cm H20.69 The diagnostic yield of eBUS-
TBNA with -20 and -40 cm H20 was similar (75.8 and 
83.3%, respectively). The yield of eBUS-TBNa carried 
out without suction was lower (63.6%), but this result 
may be influenced by the abnormally high rate of inade-
quate samples (29%) retrieved in the no-suction group.69 
Shiroyama et al. compared EBUS-TBNA with suction 
set at -20 (low-pressure group) and -30 cm H20 (high-
pressure group) and found out that sensitivity, specificity 
and accuracy were not statistically different between the 
two groups. However, a significantly higher number of 
patients in the high-pressure group had diagnostic his-
tology cores as compared to the low-pressure group (90 
vs. 28).
Based on the results of these studies both the WaBiP 
and the accP Guidelines conclude that eBUS-TBNa can 
be performed either with or without suction. However, 
many aspects related to the role of suction with EBUS-
TBNa, such as the possible differences in the yield for 
cancer genotyping and the possible differences in the yield 
with different needle size remain unknown and require 
further study.
Needle size
EBUS-TBNA can be performed with a wide array of nee-
dles of different size (25-gauge, 22-gauge, 21-gauge, and 
19-gauge) and materials (nitinol, stainless steel). although 
some studies have compared the diagnostic success of 
EBUS-TBNA performed with needles of different size,71-73 
only two randomized trials analyzed this topic.74, 75
Oki et al. randomized 60 patients to undergo eBUS-
TBNA with either a 21-gauge or a 22-gauge needle.74 
No differences were found between the two groups in 
terms of diagnostic yield, specimen adequacy, and re-
trieval of histology cores.74 Very recently, dooms et al. 
performed a randomized controlled trial aimed at com-
paring the recently introduced Flex 19-gauge needle 
tic yield in 102 potentially operable patients undergoing 
EBUS-TBNA for mediastinal staging of known/suspected 
lung cancer.3 The authors found out that 100% adequacy 
and 95% sensitivity were achieved by the 3rd needle aspi-
ration and did not increase with a 4th one.3 
Two studies assessed the same topic in sarcoidosis.65 
In the study by Oki et al. 109 patients underwent EBUS-
TBNa for 184 lesions.65 The cumulative yields through 
the first, second, third, fourth, fifth, and sixth passes for 
the main target lesion were 63%, 75%, 82%, 85%, 86% 
and 88%, respectively. In the 55 patients that underwent 
eBUS-TBNa for multiple lesions, the cumulative yields 
of 2 passes per lesion for 2 lesions (total of 4 passes) 
and of 4 passes for single lesions were 86 and 84%, re-
spectively (P=1.00). The authors conclude that at least 4 
needle passes should be carried out from a single or from 
multiple lymph nodes to optimize the diagnostic yield of 
EBUS-TBNA in patients with suspected sarcoidosis. Sun 
et al. performed a prospective study of eBUS-TBNa in 
sarcoidosis aimed at determining the predictive factors of 
diagnostic success.66 in the multivariate analysis, the short 
axis diameter and more than 1 needle pass per lymph node 
were independent risk factors associated with a positive 
pathology. The authors conclude that the operators should 
select the largest mediastinal or hilar lymph node acces-
sible and puncture with 3 to 5 passes to optimize the di-
agnostic yield of eBUS-TBNa in sarcoidosis if rOSe is 
unavailable.66
A single retrospective study analysis has examined the 
number of eBUS-TBNa aspirations (using a 21-gauge 
needle and ROSE) required to ensure maximal diagnostic 
yield for mutational analysis (eGFr, KraS and aLK).67 
This retrospective study showed that specimens were ad-
equate for molecular analysis in 95% of all cases with a 
median number of 4 aspirations per patient.67 Based on 
this study, the WaBiP guidelines suggest that a total of 4 
needle passes should be obtained from the target whenever 
molecular testing is planned, wherever the ACCP guide-
line recommend that additional samples, beyond those 
needed to establish the diagnosis, be obtained for molecu-
lar analysis.
Use of suction
EBUS-TBNA can be carried out with or without suction. 
The difference between the two methods is that in the tech-
nique without suction, also referred to as transbronchial 
needle capillary sampling (TBNcS), the needle is moved 
back and forth within the target lymph node without ap-
plying continuous suction through a 10-20 mL syringe.
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stained for ROSE and the other/s is/are fixed in alcohol 
95% for Papanicolaou. The slides should be fixed quickly 
in order to avoid phenomena of desiccation e/o cellular de-
generation and should be constituted only by one cellular 
layer, in thicker preparations the interpretation is difficult.
The remaining specimen can be placed in a solution that 
allows the preparation of cell block, core tissue prepara-
tions, blank slides for ancillary test. The needle is washed 
with saline into cytolit fixative to remove remaining cells 
for thin prep or cell block preparation.78
All this preparation facilitates IHC examination for 
proper subclassification and the molecular analysis. Some-
times, especially when the diagnosis has already been con-
firmed by ROSE, the operator can directly use the speci-
men for one of this preparation, without preparing any 
slides.
To prepare a cellblock the material inside the needle 
should be placed in formalin or cytolit preparation blow-
ing air with a syringe through the needle. Cell blocks were 
stained with hematoxylin-eosin and when indicated with 
immunohistochemical stains.80
To prepare cBs using the Tcc-cB (tissue coagulum 
clot-cell block) method, the material within the needle 
was pushed out using the inside stylet, instead of using a 
syringe. The material was collected onto a piece of filter 
paper with the needle tip directed in a tight circular motion 
to build up a cone shaped clot of tissue and blood mixture. 
The clot was slightly air dried on the filter paper, mostly to 
ensure that the coagulum was congealed and the cellular 
elements were not quickly dispersed in a liquid medium. 
The tissue coagulum was wrapped with filter paper, gently 
slid into a formalin container, and processed in the histol-
ogy laboratory. after histological processing, 4-5 micron 
sections were mounted on uncharged glass slides. Sections 
stained with hematoxylin and eosin (H&E) were used to 
assess cellularity and morphology.79
Especially when the material on the glass slide are abun-
dant and bloody, it can be left there coagulating for some 
minutes, and once coagulated transferred to 10% forma-
lin through the use of a blunt needle or a bisturi. This clot 
is partly stained H&E, and partly used for molecular and 
immunohistochimic analysis. Any BCC that was expelled 
on the slide was then transferred to 10% formalin using to 
blunt needle. 
When a core of tissue is identified on the slide, it’s im-
portant avoid to leave it there because it would be wasted 
material if stained as a slide. Therefore, it is important to 
take it with a blunt needle and transferred in 10% formalin 
where can be processed adequately.
with a standard 22-gauge needle in 78 patients with sus-
pected lung cancer.75 The primary endpoint was the pro-
curement of a histology core. The secondary endpoints 
were diagnostic yield, specimen quality (especially 
its bloodiness), tissue surface area, procedure-related 
complications, and performance for next generation se-
quencing (NGS).75 Surprisingly, the only advantage as-
sociated with the use of the Flex 19-gauge needle was 
a trend towards a larger tissue surface area of histology 
cores, whereas no difference was found for any of the 
remaining endpoints, including clinically relevant ones 
such as diagnostic yield, complication rate, and success 
of NGS testin.75
Based on these evidences, both the international guide-
lines suggest that there is currently insufficient evidence to 
recommend a specific needle size or type.
Stylet use
Dedicated EBUS-TBNA needles come with an inner sty-
let which is commonly used to expel the tissue (usually 
airway wall material) that is loaded into the tip once it it 
thrust through the airway wall into the target lesion (i.e. 
lymphadenopathy). recently Scholten et al. performed a 
study aimed at verifying if the inner stylet of eBUS needle 
is really useful.76 The authors enrolled 121 patients and 
sampled 194 lymph nodes, using for each sampled lymph 
node both the with stylet and without stylet technique.76 
Interestingly no differences were found between the stylet 
and no-stylet groups in terms of sample adequacy (82% 
vs. 87%, respectively), diagnostic yield (25.7% vs. 25.2% 
in the per lymph node analysis). There was a high degree 
of concordance for both adequacy (84%) and diagnostic 
yield (95.4%) between the two techniques. The authors 
conclude that omitting the stylet use during eBUS-TBNa 
does not affect the diagnostic outcomes and reduces the 
complexity of the procedure (Table II).77
Specimens
Once you get a good specimen it is extremely important to 
process the specimen in a proper way to achieve maximum 
results. Handling of the specimen may differ between cen-
ters and the operator should use the type of preparation 
according with his pathologist’s preferences.62
For pushing out the specimen the internal stylet can 
be used and if the material is not enough, can be blowed 
air with a syringe through the needle. The first few drops 
are placed on the slide glass and then smeared in order to 
obtain 2/4 slide; one slide are air-dried and immediately 
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• decide if the material is sufficient for the eventual 
icc and molecular analysis;
• decide which kind of sample preparation are indicated 
in the different moment of the exam.
it is demonstrated that also a trained pulmonologist can 
reach a good competence on this kind of evaluation. For 
this reason also the pulmonologist should learn rOSe or 
at least to know how to interpret the cytologic evaluation 
in order to maximize the efficiency of the procedure.
Evidence regarding ROSE
Only three randomized trials evaluated the influence of 
rapid on-site evaluation on the success diagnostic rate of 
eBUS-TBNa.82-84 Oki et al. randomized 120 patients with 
mediastinal lymphadenopathy to undergo eBUS-TBNa 
with or without ROSE by a cytotechnologist.82 although 
patients in the rOSe group had less biopsy sites sampled 
(11% vs. 57%, P<0.001) and a lower number of punctures 
per lymph node (2.2 vs. 3.1, P<0.001), mean bronchosco-
py time (22.3 vs. 22.1 min), sensitivity (88% vs. 86%) and 
diagnostic accuracy (89% vs. 89%) were similar between 
the two groups.82 in a study aimed at evaluating the role 
of EBUS-TBNA with and without ROSE for lung cancer 
genotyping, Trisolini et. al. enrolled 197 patients with sus-
pected lung cancer.83 again, neither adequacy (94.9% vs. 
97.7%) nor sensitivity (96.9% vs. 95.1%) were different 
in the ROSE as compared to the no-ROSE groups, where-
as a 10.5% more patients in the rOSe group achieved a 
complete cancer genotyping.83 Finally, madan et al. per-
formed a complex randomized trial aimed at evaluating 
the role of conventional versus EBUS-guided TBNA with 
and without ROSE in sarcoidosis.84 Eighty patients were 
randomized 1:1:1:1 to undergo c-TBNA without ROSE, 
c-TBNA with ROSE, EBUS-TBNA without ROSE, and 
EBUS-TBNA with ROSE. In the two EBUS groups, no 
difference in diagnostic yield was seen in the ROSE group 
(67%) versus the no-rOSe group (68%).84
More recently, a systematic review with meta-analysis 
(5 studies, 618 patients) summarized the evidence on the 
impact of rOSe on the diagnostic yield of both c-TBNa 
and EBUS-TBNA, and confirmed that the on-site review 
does not increase diagnostic yield or specimen’s adequacy, 
but is associated with a fewer number of needle passes and 
with a lower requirement of additional bronchoscopy pro-
cedures to make a final diagnosis.81
Based on these findings, both the WABIP and the ACCP 
guidelines suggest that there is insufficient evidence to 
recommend that ROSE be used with every EBUS-TBNA 
procedure.
acquire a competence about the acquisition and Prepara-
tion of Specimens from eBUS-TBNa is fundamental as it 
is the knowledge of the WABIP guideline on this argument.
ROSE
One of smears obtained by eBUS TBNa can be air-dried 
and immediately stained. Diff-Quik is the mostly used pro-
cedure but other stains like rapid hematoxylin, can be used, 
based on the pathologist’s preferences. rapid on-site evalu-
ation of the aspirates does not increase diagnostic yield or 
specimen’s adequacy, but is associated with a fewer number 
of needle passes and with a lower requirement of additional 
bronchoscopy procedures to make a final diagnosis.81
reduce the number of lymph node’s stations to sample 
can have a high impact on the everyday practice; for exam-
ple, if ROSE shows malignant cells in a N3 lymph node, 
additional aspirations of the N2 or N1 is not necessary.
So the role of the cytopathologist is to:
• define if a sample is adequate;
• decide if the material is enough for a precise diagnosis;
• formulate a preliminary diagnosis;
Table II.— Summary of the main recommendations from available 
guidelines.
• Insertion of endoscope through upper airways and vocal cords, bearing 
in mind the correct angles providing different endoscopic visualizations
• Presentation of main lymph nodes (2, 4, 7, 10, 11) and vascular stations 
and their relationship
• positioning of the transducer 
• biopsy sampling, according to the 18 procedural steps described by 
mehta:77
 1. Advance EBUS needle through the working channel with scope in 
neutral position
 2. Secure needle assembly by sliding the flange, locking it in place
 3. Release the sheath screw
 4. Advance and lock the sheath when it is visualized at the top right-
hand corner of the monitor
 5. Locate the target lymph node to be sampled using US imaging
 6. release the needle guard
 7. Advance the needle using the quick “jab” method
 8. Visualize needle entering target node with US
 9. Move the stylet in and out a few times to dislodge debris within the 
needle
10. Withdraw the stylet
11. attach suction syringe to the needle
12. apply suction
13. Move the needle back and forth within the node >10 times
14. release suction
15. retract the needle into the sheath
16. Secure the needle guard
17. Unlock the needle assembly
18. remove the needle and sheath; collect the specimen
• correct placing of specimen on slide and cell block
• Preparation and interpretation of rOSe
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Strategies’ skills
competence is not only referred to the practical part, in 
fact the strategies in planning every single case are not 
less important. These are principally based on the knowl-
edge of the recommendations from the currently published 
guidelines regarding diagnosis and staging of lung cancer, 
the eBUS technique and treatment of the specimens.53, 54
To make an accurate staging with EBUS/EUS, follow a 
precise order of sampling is necessary and depends mainly 
on the side and localization of the tumor determined by cT 
scan findings. If possible, distant metastases (M1) should 
be excluded first, followed by lymph node staging in the 
order N3 (contralateral lymph nodes) → N2 (ipsilateral 
mediastinal and subcarinal lymph nodes) → N1 (ipsilat-
eral hilar lymph nodes). For patients with suspected N2 
disease infiltration of only single N2 lymph nodes (N2a, 
stage IIIA3) has to be differentiated from infiltration of 
more than one N2 lymph node region, clusters of involved 
lymph nodes in one or more N2 stations, or large N2 lymph 
nodes with extracapsular invasion (N2b, Stage IIIA4) . It 
is important because it can differentiate between resect-
able and unresctable N2.52
Based on the erS/eSTS/eSGe recommendation it is 
possible to distinguish between two main kind of staging:
1. the target staging (or “Hit and run”) where the opera-
tor should puncture only the nodes suspicious on cT and/ 
or PeT. The hit and run approach can be performed in pa-
tients that does not need a staging, for example the clear ad-
vanced stage NScLc. moreover, especially in this last case 
the operator must guarantee a sufficient material for ICC 
and molecular analysis in order to ensure a personalized 
therapy. So, it is important find the more efficient examina-
tion to get appropriate material for these kind of investiga-
tions, preferring specimens (if possible; i.e. endobronchial 
or transbronchial biopsy) and/or clot core and cell block.
2. a systematic echoendobronchial evaluation of the me-
diastinal lymph node stations can be performed with some 
different strategies which have in common an essential fac-
tor: the evaluation of the main mediastinal node stations, 
meaning at least 4r 4L 7 10r 10L 11r 11L. Sampling of at 
least three different mediastinal nodal stations (4r, 4L, 7). 
The largest node measuring >5 mm (short axis diameter) 
on ultrasonography, as well as FDG-avid nodes within each 
of these nodal stations should be sampled for pathologi-
cal analysis. On indication, the hylar station can be biop-
sied.11 The operator, based on knowledge of the guidelines, 
should perform a complete mediastinal staging in proven 
or suspected NScLc and an abnormal mediastinum by cT 
Procedural	steps	with	EUS/EUS-B
eUS and eUS-B can be safely done as an outpatient pro-
cedure in a bronchoscopy unit.
The suite should be properly equipped for patient moni-
toring.
A secure intravenous access is mandatory and specific 
anesthetic drugs should be at hand.
A certified bronchoscopist with formal endosonography 
training, two nurses and an anesthesiologist, in case of 
deep sedation or general anesthesia, should be the minimal 
personnel requirements to perform the procedure securely.
The step-by-step eUS-B procedure:
1) insert the scope through the mouth (through the use 
of a mouthpiece) into the esophagus;
2) suction should be used only in intermittent manner to 
avoid deflating esophageal tract completely;
3) advanced the scope under visual control to the gastric 
fundus;
4) from this moment on continuosus suction is manda-
tory to facilitate the contact between the US trasducer and 
the esophageal wall;
5) at the cardia region the trasducer is turned back until 
the abdominal aorta is clearly visualized;
6) identify the left adrenal gland (LAG) going down the 
aorta up to the celiac trunk and turned the scope counter-
clockwise (if physician standing behind a patient the tras-
ducer turns to the left). The LAG is behind the celiac trunk;
7) the trasducer is brought back to its standard neutral 
position at the cardia and see in front the liver and to the 
right you can follow the hepatic veins to the inferior vena 
cava;
8) search for LFN7 station. Move the scope back from 
distal to the middle part of esophagus and visualized ante-
riorly the left ventricle, the atrioventricular valves and the 
left atrium. Withdrawing the scope slightly more, subcari-
nal lymph node (7) are clearly visible;
9) search for LFN4r station. move slightly to the right 
the scope and localize the right pulmonary artery in a 
trasverse section. Retreating the scope and looking ante-
riorly behind the azygos vein the 4r staion can be found;
10) search for LFN4L station. Now rotating the EBUS 
scope to the left will permit to detect the lower paratra-
cheal (4L) and deeper aort-pulmonary window LF (station 
5) betwenn the pulmonary artery and aorta (mickey mouse 
effect);
11) search for 2L station. as the eUS-B scope is further 
withdrawn, the left subclavian artery and the 2L staion are 
identified on the left.
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with lung cancer. When such features are observed the risk 
of metastatic node is higher and multiple needle aspira-
tion should be performed even if the rOSe reported only 
benign lymphocytes.86
another important contribution in identifying lymph 
node’s characteristics for a better selection of punctures 
site could be made by ultrasound elastography. elastog-
raphy is an imaging methodic that can assess the stiffness 
of different tissue considering their deformation under 
compression.87 The stiffness’ degree is reported into a col-
or-coded image on ultrasound display: harder tissues are 
shown in blue; intermediate/normal tissues in green; softer 
tissues in red.88
malignant tissues are usually stiffer than normal healthy 
tissues and may be distinguished through a qualitative 
evaluation of the color pattern or through a semiquantita-
or CT-PET. This “complete” mediastinal staging is based 
on the concept that identification of one malignant lymph 
node does not mean that mediastinal staging was optimal. 
One strategy regards basically the order of visualization. 
So it is possible to decide the order of evaluation consider-
ing where the tumor (T) is located during a NSCLC stag-
ing. For example if “T” is located in the RLL is possible to 
evaluate 10L, 11L and 4L (representing the N3), then 7 and 
4 r (representing the N2) and at the end 10r and 11r (rep-
resenting N1), follow this order also for sampling. Another 
strategy consists in always use the same order of evalua-
tion. For example is often used an order linked to the six 
EBUS landmarks, starting from 4L, moving to 7 and then 
10L/11L, azygos vein, 4r and at the end 10r /11r. can be 
useful using this last approach because you can routinely 
follow the same order and automatically better remember 
it, but it is fundamental not to follow this order for sam-
pling, considering that in this last case the order must al-
ways be N3->N2->N1, unless the needle is changed when 
the operator moves from N1 to N2 or from N2 to N3.
Lymph node characteristics
The operator should be able to analyze the lymph nodes 
features in order to select which nodes should be punc-
tured considering the probability of malignancy. Sono-
graphic characteristic are helpful in predicting lymph node 
malignancy both for superficial lymph nodes and for me-
diastinal and hilar nodes.85
The main lymph node sonographic features that can be 
assessed through EBUS are: 1) size (short axis) less or 
more than 1 cm; 2) shape (oval or round); 3) margin (indis-
tinct or distinct); 4) echogenicity (homogeneous or hetero-
geneous); 5) presence or absence of central hilar structure; 
and 6) presence or absence of coagulation necrosis sign85 
(Figure 9, 10).
High negative predictive values were found considering 
these characteristics, so that when node EBUS malignant 
features are not detected the true negativity of the sampled 
lymph node is more likely. Round shape, distinct margin, 
heterogeneous echogenicity, and presence of coagulation 
necrosis sign are instead independent predictive factors for 
nodal metastasis.86
Moreover a vascular image pattern classification of 
lymph node using doppler-mode ultrasound during 
EBUS-TBNA was described. Considering the lymph node 
vascularization as blood-flow signals, other than central 
intranodal blood flow and bronchial artery inflow signal 
from the bronchial lumen, the operator may predict the 
probability of malignancy of the lymph nodes in patients 
Figure 9.—Lymph node with malignant characteristics.
Figure 10.—Lymph node with benignant characteristics.
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tive measurement (i.e. Strain ratio, Strain Hystogram (Fig-
ure 11, 12).87, 89, 90
eBUS elastography could be considered an effective di-
agnostic technique for the differentiation between benign 
and malignant lymph nodes considering the preliminary 
data on this method; moreover, circumscribed metastatic 
infiltration area could be more easily detected allowing a 
precise puncture of suspicious area within the node.91
a correct evaluation of these characteristics is essential 
for an efficient assessment of the mediastinal nodes.
The operator should be able to analyze all the lymph 
nodes features in order to select which nodes should be 
sampled based on its features. all these lymph node se-
Figure 11.—elastography-strain hystogram.
Figure 12.—elastography-strain ratio.
lection criteria could be useful especially during a eBUS/
EUS-(B) systematic staging where many lymph nodes can 
be detected. When all characteristics are sonographically 
determined not metastatic, we might be able to avoid un-
necessary biopsies in such lymph nodes.
Moreover, when a node is sampled and ROSE report 
only benign lymphocytes, we might decide to continue the 
sampling on such node based on the lymph node charac-
teristic: if the node’s feature suggest benignancy we could 
avoid unnecessary passes and change node, if the node’s 
features suggest malignancy subsequent needle aspirations 
should be taken.
This kind of approach could allow to save time in medi-
astinal nodal staging, could reduce the risk of false-negative 
cytopathological results, and could prevent to repeat endo-
sonographic sampling procedures and surgical staging.
Practical	anatomy-echoendoscopy	correlation
Lymph node stations reachable with EBUS and/or EUS-
(B) are reported with the specific images and anatomic 
features of each one
Station	1:	low	cervical,	supraclavicular	and	sternal	notch	
nodes92, 93
Anatomy
• Upper border: lower margin of cricoid cartilage.
• Lower border: clavicles bilaterally and, in the mid-
line, the upper border of the manubrium.
• The midline of the trachea serves as the border be-
tween 1R and 1L.
Echoendoscopy
When enlarged and adiacent to the trachea is possible to 
find these nodes in the first centimetres of the trachea, just 
below the vocal cords. From 9 o’clock position to 12: 1L; 
from 12 o’clock position to 15 1R.
There is not a specific US pattern.
Note: it is a rare detection but always represent a N3 in 
the NScLc staging (Figure 13).92, 93
Station 2 (upper paratracheal lymph nodes)92, 93
• 2r
Anatomy
• Upper border: manubrium and apex of lungs (later-
ally).
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The left jugular vein and the left common carotid can be 
individuated in this area helping as a landmark, moreover 
the lower border of this station is clearly visible at EBUS 
(superior rim of the aortic arch).
This station can be reached also through an esophageal 
approach, finding also in this case the superior border of the 
aortic arch and exploring the region upon this landmark.
Station	3A	(prevascular	lymph	nodes)92, 93
Anatomy
• Upper border: apex of the chest
• Lower border: carina,
• anterior border: sternum.
• Posterior border: the superior vena cava (SVc) on the 
right and the left common carotid artery on the left.
Echoendoscopy
Sometimes these nodes can be individuated, but being lo-
cated anterior to the great vessels (common carotid and jug-
ular vein), they cannot be sampled. it is a rare detection.92, 93
Station 3P (retrotracheal lymph nodes)92, 93
• Upper border: apex of the chest.
• Lower border: carina.
• Anterior border: the posterior wall of trachea.
Echoendoscopy
This station can be reached exploring the posterior wall of 
the trachea (6-7 o’clock position). It is a rare detection but 
can be usually reached also with EUS-(B). There are not 
specific structures to be used as landmarks.92, 93
• Lower border intersection of caudal margin of left 
brachiocephalic vein with the trachea.
• Located to the right of the left lateral border (not the 
midline) of the trachea.
Echoendoscopy
One third of the distance of the trachea from the vocal cord 
represent the endobronchial position in which we can nor-
mally find this node. In this area, around 1-2 o’clock posi-
tion is possible to individuate the right common carotid ar-
tery and the right subclavian artery that are normally near 
this lymph node station.
Both the upper border and the lower border of this sta-
tion is difficult to define with endobronchial ultrasound. A 
trick can be used to individuate at least the lower border of 
this station, finding the lower border of 2L (superior rim 
of the aortic arch) and then turning the scope on the right 
remaining at the same cranio-caudal level (Figure 14).
• 2L
Anatomy
• Upper border: manubrium and apex of lungs (laterally).
• Lower border: superior border of aortic arch.
• Located to the left of the left lateral border (not the 
midline) of the trachea.
Echoendoscopy
as for the 2r the one third of the distance of the trachea 
from the vocal cord represent the endobronchial position 
but it’s important to remember that the 2L are located to 
the left of the lateral border of the trachea, so that can be 
found at 9-10 o’clock position.
Figure 13.—Lymph node station 1. Figure 14.—Lymph node station 2r.
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which the azygos converges into the superior vena cava 
with a slightly rotation of the scope. The azygos vein dis-
tinguishes between 4R and 10R station and this is essential 
in the NScLc staging (Figure 15).
• 4L
Anatomy
• Upper border: superior border of aortic arch.
• Lower border: superior rim of the left main pulmo-
nary artery.
• Located to the left of the left lateral border (not the 
midline) of the trachea.
• The left lateral-most extent of 4L is the ligament arte-
riosum, separating this station from station 5.
Echoendoscopy
This station is located at the 9 o’clock position, at the level 
of the carina, just above the left main bronchus ostium. at 
this level is possible to individuate one of the more com-
mon landmarks: the so called micky mouse window. Infact 
it is possible to see the aorta and pulmonary artery and the 
4L lymph node (representing the head of micky mouse) 
between this main vessel (representing the two ears of 
micky mouse) medial to the ligamentum arteriosum.
Moreover is also easy to recognize the upper and lower 
borders of this station, considering that are pretty much 
included in the “micky mouse” window.
This station is easy to visualize through the esophageal 
approach. in fact also in this case it is possible to recog-
nize the “mickey mouse effect” just withdrawing the scope 
slightly from the heart view and rotating the scope to the 
left (Figure 16).
Station 4 (Lower Paratracheal Lymph Nodes)92, 93
• 4r
Anatomy
• Upper border: intersection of caudal margin of left 
brachiocephalic vein with the trachea
• Lower border: lower border of azygos vein;
• Located to the right of the left lateral border (not the 
midline) of the trachea.
Echoendoscopy
This station is often located at 1-2 o’clock position, two-
four intercartilage space above the carina. at this level the 
node can be positioned just in front of the superior vena 
cava distally visible as a specific landmark (img). It is use-
ful to find the azygos vein (representing the lower border 
of this station) and then explore the region above this ves-
sel in order to easily find this region.
The nodes of this station can extend anterior to the tra-
chea. At this level are known as anterior carinal lymph 
nodes and are located at 11.30-12 o’clock position. It is 
fundamental to adequately explorate all the 4R region, 
without forgetting this anterior zone.
A trick can be used to individuate the upper border of 
this station, finding the upper border of 4L (superior rim 
of the aortic arch) and then turning the scope on the right 
remaining at the same cranio-caudal level.
Even more important is individuate the lower border of 
this station, represented from the lower border of the azy-
gos vein. When you are looking for the azygos (2 o’clock 
position at the end of the trachea) you can make sure that 
the individuated vessel is the azygos finding the point in 
Figure 15.—Lymph node station 4r. Figure 16.—Lymph node station 4L.
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avoiding the aorta.52 rarely is possible to pass above the 
aortic arch and to sample it and using a 25G-needle may 
be used.52
Station 7 (subcarinal lymph nodes)92, 93
Anatomy
• Upper border: carina.
• Lower border on the left: upper border of the left low-
er lobe bronchus.
• Lower border on the right: lower border of bronchus 
intermedius.
Echoendoscopy
considering that this lymph node station is located inferior 
to the carina, it can be approached in the medial wall of 
either the right and the left main bronchus. The pulmo-
nary artery and trunk are often visible anteriorly, and the 
esophagus is sometime visible distally. The borders of sta-
tion seven are more clearly defined by bronchoscopic view 
than US landmarks.
This station is clearly identifiable with EUS/EUS-B. 
The left atrium and the pulmonary artery represent the 
EUS landmarks of the station. The nodes (especially the 
posterior group) are located in between of this structures; 
if not identified just slightly rotate the scope on the right at 
this level (Figure 17, 18).
Station 8 (paraesophageal lymph nodes)92, 93
Anatomy
Adjacent to the esophageal wall but excluding the subcari-
nal (station 7) lymph nodes.
Station 5 (Subaortic Lymph Nodes)92, 93
Anatomy
• Upper border: lower border of aortic arch.
• Lower border upper rim of left main pulmonary ar-
tery.
• Station 5 lymph nodes are located lateral to the liga-
ment arteriosum, that separate this station from 4L).
Echoendoscopy
This lymph node station is visible at the same level of the 
4L station (9 o’clock position at the level of the carina) but 
distally. In fact it is identifiable between the aorta and pul-
monary artery, but lateral to the ligamentum arteriosum; so 
distally in respect of the transducer. although this station is 
often visible, it is not easy to sample it due to this position 
and interposition of the pulmonary artery/aorta. The larger 
ultrasonic window and better needle maneuverability of 
the EUS scope allows a better approach of this station.
Station	6	(para-aortic	lymph	nodes)92, 93
Anatomy
• Upper border: Imaginary horizontal line drawn tan-
gentially along the upper border of aortic arch.
• Lower border: lower border of the aortic arch.92, 93
Echoendoscopy
Same endoscopic position of 4L and 5, or slightly above, 
in order to better visualize these nodes located on the outer 
aspect (anterior and lateral) of the ascending aorta and 
aortic arch. This station is are even more difficult sample 
Figure 17.—Lymph node station 7, Figure 18.—esophagous.
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Station	10	(hilar	lymph	nodes:	adjacent	to	the	mainstem	
bronchi	and	the	hilar	vessels)92, 93
• 10r
Anatomy
• Upper border: lower rim of the azygous vein;
• Lower border: interlobar region.
Echoendoscopy
This lymphnode station is located anterior to the right 
main bronchus about 12-1 o’clock position 1-2 intercarti-
lage space below the carina.
Positioning the transducer at this level (anterior aspect 
of the right main bronchus) the nodes of this station can 
be reached beside the right pulmonary artery (Figure 20).
To easily find the upper border, the lower border of azy-
gos vein should be identified at 2 o’clock position at the 
end of the trachea. To make sure that the individuated ves-
sel is the azygos the point in which the azygos converges 
into the superior vena cava with a slightly anterior rotation 
of the scope should be found. The azygos vein distinguish-
es between 4R and 10R station and this is essential in the 
NScLc staging.
The lower border (upper lobe carina) can be well identi-
fied through the endoscopic view.
• 10L
Anatomy
• Upper border: upper rim of left pulmonary artery.
• Lower border: interlobar regions.
The upper borders coincide with the lower border of sta-
tion 7.
• Upper border on the left: upper border of the left low-
er lobe bronchus.
• Upper border on the right: lower border of bronchus 
intermedius.
• Lower border: the diaphragm.
Echoendoscopy
This station can be reached only by using the esopha-
geal approach (eUS or eUS-B). it can be found identify-
ing the right atrium and looking for its about this high, 
slightly rotating the scope on the right and/or the left.
Considering that both the upper border and the low-
er border of this station are defined by bronchial land-
marks, it is impossible to identify these through EUS-(B) 
(Figure 19).
Station 9 (pulmonary ligament lymph nodes)92, 93
Anatomy
These lymph nodes lie within the pulmonary ligament.
• Upper border: inferior pulmonary veins.
• Lower borders: diaphragm.
Echoendoscopy
The lymphnode station 9 can be visualized only through 
the esophageal approach (eUS or eUS-B). The scope 
should be positioned in order to identify the diaphragm 
on the left corner of the display and the right atrium on 
the right. at this level, the left pulmonary ligament lymph 
nodes (station 9) can be detected and sampled.
Figure 19.—Lymph node station 8. Figure 20.—Lymph node station 10r.
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intermedius, lateral to the right middle lobe. at this level 
is possible to recognize the right pulmonary vein leading 
to the left atrium superiorly, and the descending branch of 
pulmonary artery inferiorly.
• 11L
The lymph nodes of this station are located between the 
left upper lobe and the left lower lobe bronchus. Position-
ing the EBUS transducer just below the spur of the upper 
lobe carina the nodes of this station are visualized and the 
left pulmonary artery and the left pulmonary vein can be 
identified anteriorly (Figure 23).
Sometimes it is possible to visualize and sample station 
Echoendoscopy
Positioning the eBUS transducer on the anterior/superior 
wall of the left main bronchus, just above the interlobar 
region, the station 10L can be reached. Left pulmonary ar-
tery and pulmonary trunk are visible at this level and left 
atrium can be visualized more inferiorly.
The upper border (superior rim of pulmonary artery) is 
easily reachable through the ultrasound view of the micky 
mouse window (9 o’clock position at the level of the ca-
rina); whereas the lower border (upper lobe carina) is bet-
ter identifiable through the endoscopic view.
Sometimes is not easy to reach a good US view of this 
station due to the not excellent adherence of the transducer 
on the left main bronchus wall (Figure 21).
Station 11 R and L (interlobar lymph nodes)92, 93
Anatomy
Located distal to the bifurcation of the mainstem bronchi 
(between the origins of lobar bronchi).
• 11rs (11r superior)
The lymph  nodes of this station are located between the 
bronchus intermedius and the right upper lobe. Position-
ing the EBUS transducer just below the spur of the up-
per lobe carina can be visualized the nodes with the right 
pulmonary artery superiorly and right pulmonary vein and 
pulmonary artery branch inferiorly. in fact this station are 
usually surrounded by the hylar vessel that can complicate 
the sample of the small nodes (Figure 22).
• 11ri (11r inferior)
This station is located at the distal wall of the bronchus 
Figure 21.—Lymph node station 10L.
Figure 22.—Lymph node station 11rs.
Figure 23.—Lymph node station 11L.
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trainees. Furthermore, the learning curve may result lon-
ger than predicted due to poor availability of suited pa-
tients, or to the trainer’s resistance to delegate a beginner 
to potentially risky procedures.
Role	of	virtual	reality	simulators	in	training	EBUS-TBNA
In this context, the role of simulation is gaining interest 
and a raising amount of evidences confirm its role in train-
ing beginners.
Basically, two different simulation instruments exist 
providing low and high fidelity reproduction of anatomic 
structures and land mark, respectively. It is demonstrated 
that high fidelity simulation is not necessarily superior to 
low fidelity, especially in the training of basic broncho-
scopic skills,97, 98 in order to improve trainee’s confidence 
and ability to maneuver the scope into the airways. Low 
fidelity simulation is usually cheap, with different mod-
els providing various degrees of realism. The purpose of 
this system is to emphasize psychomotor skills acquisi-
tion without distraction from the lack of knowledge of 
the anatomy in the early phases of training.99 There are 
relatively few studies assessing the impact of low-fidelity 
compared with high-fidelity simulation training on bron-
choscopy skills, but a recent meta-analysis suggests that 
low-fidelity models may in fact be preferred in some 
situations100 so, at present, they are considered comple-
mentary.101 As a general rule, low-fidelity models may 
be more suitable for the most basic bronchoscopy tasks 
while simulation of more advanced procedures, such as 
EBUS and navigation bronchoscopy, are likely to be of-
fered by high-fidelity systems.102 Indeed, high fidelity 
simulation adds several strengths to learning due to its 
realism that enables to recreate real life settings and to 
mimic every single procedural step. This is particularly 
evident in the EBUS-TBNA high fidelity simulators (i.e. 
endoscopy Vr simulator [cae Healthcare, montreal, 
Quebec, canada] and the Gi-BrONcHmentor [Simbio-
nix Ltd, Airport City, Israel]). Several studies have dem-
onstrated that they are able to provide a relevant insight 
to beginners, shortens their learning curve, especially in 
its initial part103 and enable them to approach the real pa-
tient with a higher self-confidence and minimizing the 
risk of malpractice. Furthermore, considering the risk of 
damaging the scope deriving from a not proper use of 
needles and scopes, virtual simulation warrants also a rel-
evant money sparing.
another pivotal aspect of training through simulation, 
is represented by the realism of the environment in which 
the simulation takes place. For participants to fully engage 
12 and 13 almost exclusively if are located in the lower 
lobe with anatomical features that make that possible.
Distinguish between mediastinal lymph node stations 
could be challenging; but in some cases is essential per-
form an accurate staging and avoid under or overstaging.
distinguishing station 1 from station 2 lymph nodes 
can be difficult when the lymph nodes are off midline and 
landmarks are not present. This is clinically important be-
cause stage N2 tumors can be misclassified as N3 or vice 
versa, but luckily these findings are very rare.
On the contrary, it is common to have to distinguish 
stations 4 from station 10 (both r and L). This is impor-
tant because N1 tumors can be misclassified as N2 or N2 
can be misclassified as N3 (and vice versa).94. in fact if 
a tumor (T) is located in the right lung, a 10r represent 
a N1 while the 4R a N2; if the tumor is the left lung the 
10R will be a N3 while the 4R a N2. Obviously, differ-
ent therapeutic options are reserved for this different N 
stage.
In this case is possible to use the US landmark repre-
sented by the lower rim of the azygos for the 4R and the 
upper rim of the pulmonary artery for the 4L. it could 
be easier for station 4L in which generally the nodes of 
the respective stations are well separated by the pulmo-
nary artery and the area to explore is smaller than 4R one, 
whereas, in relation to station 4R, it is fundamental to find 
a smaller vessel as the azygos vein that can well distin-
guish 4r from 10r.
classifying large lymph nodes that span more than 1 
station can be difficult, but it is suggested to assign the sta-
tion where the node predominantly reside.92
Theoretical and practical training
The complexity of this advanced diagnostic procedure can 
make learning this procedure a difficult and time-consum-
ing process, especially when a classical experiential teach-
ing model is applied.94, 95
Indeed, the traditional apprenticeship model by which 
patients suffer the burden of technical training is currently 
ethically and legally questionable and exposes the supervi-
sor, the trainees and the teaching hospital to several pro-
cedural and medical issues. For instance, trainee involve-
ment significantly increased EBUS duration and the dose 
of local and general anesthesia used for the procedure and 
the diagnostic yield was lower when a trainee participated 
the exam.96 As a consequence, direct patient care would 
not uncommonly become overwhelming and a source of 
significant frustration and anxiety for both trainers and 
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Future	perspectives	in	EBUS-TBNA	virtual	reality	simu-
lation
To date, high fidelity simulation enables the beginner en-
doscopist to reach basic skillfulness and confidence to start 
real patient endoscopy without increased risk of signifi-
cant impact on procedure proficiency.
Although extremely useful, this is still not enough. Fur-
ther technologic improvement is highly desirable so that 
simulators may be soon able to provide specific, rarer and 
difficult to experience, clinical scenarios such as needle 
breakage, massive bleeding, severe hypoxemia, etc., the 
practitioner could be demanded and challenged to man-
age. This would allow, exactly like it happens for profes-
sional aircraft pilots, to experience emergency protocols 
that are very unlikely in real life practice but that, none-
theless, have to be approached in a confident and proper 
way.
Hands-on	practice:	summary	of	resources	
for training on endosonography
• Task trainer with low fidelity simulation: plastic and 
animal models, live animals and cadaver;
• Ultrasonic Bronchoscopy Simulator with EBUS and 
needle routinely used for patient;
• high fidelity with virtual reality to learn the anatomy 
and the manual dexterity required for bronchoscopy and 
sampling procedures, simulated clinical cases (BrONcH 
Mentor, BronchPilot EBUS-TBNA, BRONCH Express, 
endoVr™ interventional Simulator, Ultrasonic Bron-
choscopy Simulator). The simulator is useful when EBUS-
STaT score is >80/100;
• Observe the procedure directly or with live. Main ob-
jective: “Pattern recognition”: learn to recognize anatomic 
landmarks by observing the procedure when performed 
by an experienced colleague in the clinical setting or on 
a simulator.
• Perform eBUS under supervision. main objectives:
• “Handling of the endoscope”: learn to insert the endo-
scope and to produce the pictures, which is much more dif-
ficult than watching an experienced practitioner perform-
ing the procedure.
• “How to take biopsies”: learn to position the trans-
ducer correctly and to use a sheet and the needle.
• Learn step by step, beginning from the six EBUS 
landmarks (Stations 4L, 7, 10L, 10R, 4R, Azygos vein).
• An EBUS-EUS training programme and certifica-
tion in 3 step is available by european respiratory society 
in simulation, they need to willingly suspend their disbe-
lief. One way of helping this is through the fidelity of the 
environment or simulation suite; making the suite appear 
like the clinical environment you are trying to emulate is 
very important.
In recently published review paper, EBUS simulator 
proved to accurately stratify trainees based on their base-
line level of experience. Simulation-based training was 
demonstrated to be more efficient than the traditional ap-
prenticeship model. Physical models and virtual reality 
simulators complement each other. Simulation-based edu-
cation should be based on a mastery learning approach and 
structured as directed self-regulated learning in a distrib-
uted training programme.104 Importantly, skills acquired 
on a simulator could be transferred to real-world patients, 
this supporting a wider use of simulation.6, 103-107
in conclusion simulator-based training of operators can 
potentially shorten the learning curve of eBUS and may 
be added to the training curriculum before operators per-
form eBUS on patients.
Training	of	EUS-FNA	and	EUS-B-FNA
There is a scarcity of evidence clarifying the modalities of 
training for transesophageal ultrasound FNa for the me-
diastinal staging of lung cancer, especially amongst non-
gastroenterologists. Although specific guidelines have 
been published,108, 109 they cannot be adequately applied 
for mediastinal staging, having been developed mainly to 
provide educational support for pancreatic and other ab-
dominal samplings. Furthermore, it is not clear, but it is 
likely to be so, whether the learning curves of EUS and 
eUS-B-FNas are different from each other, especially in 
Pulmonologists. indeed, Konge et al. have recently docu-
mented that pulmonologists with knowledge of lung can-
cer staging and experience in bronchoscopy can rapidly 
improve their performance of eUS-FNa and reach a sat-
isfying competence, even if not complete autonomy, after 
20 supervised EUS-FNA procedures. However, acquisi-
tion of skills varies between individuals and in between 
consecutive procedures in the same trainee, so authors 
concluded that certification should be mandatory and 
based on assessment of performance of multiple cases.110 
Virtual-reality simulators have been proposed as providers 
of objective and unbiased assessment, but no such simu-
lators still exist for EUS-FNA of mediastinal structures 
and, furthermore, questions have been raised about the 
discriminative abilities of simulators111, 112 and need to be 
clarified.
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of Chest Physician (ACCP) has published an expert panel 
report113 assessing the current state of training and, based 
on available evidences, to issue statements on how new 
eBUS training content and guidelines should be structured 
in the forthcoming future. Similarly, a report of the con-
sensus conference on Training and competence Standards 
for the interventional Pulmonology master Program in ita-
ly has recently been made available.120 
For such a reason, the combined european Society of 
Gastrointestinal endoscopy (eSGe), european respira-
tory Society (erS) and european Society of Thoracic Sur-
geons (eSTS) guidelines do not require any quantitative 
assessment anymore, but recommend that competency in 
eBUS-TBNa and eUS-(B)-FNa for staging lung cancer 
be determined using available validated assessment tools 
(Table iii).121
Whatever the assessment instrument is, qualitative 
learning assessment must necessarily pass through a step 
by step process including all the basic skills needed to 
complete and perform the whole EBUS-TBNA procedure: 
(erS): theoretical teaching and simulation, active clinical 
observation, final assessment after 20 procedures, 3 videos 
(www.ersnet.org)
Quantitative	and	qualitative	assessment
Quantitative assessment of competences has been pro-
posed as a standard reference tool for many years. Yet, 
most of existing guidelines, still require a minimum num-
ber of eBUS-TBNa to be performed in order to certify 
trainee’s proficiency and competence.95, 113 However, it is 
well known, how the identification of a fixed minimum 
number of performed procedures threshold is somehow 
arbitrary since an extreme variability exist in individual 
learning curves. a recently published study documented 
that learning curve of subjects practicing eBUS-TBNa 
directly on the patients may be quite long and up to 120 
procedures may be required before diagnostic accuracy, 
sensitivity and specificity reach the highest levels.114 in 
a recent systematic review evaluating the EBUS-TBNA 
learning curves, 16 studies were analyzed and documented 
that the threshold numbers needed to attain proficiency in 
eBUS-TBNa varied from 10 to 100 in individual studies 
with a mean of 37–44 procedures.6
Furthermore, a learner-centric training model may be 
challenging due to limited exposure to novel technolo-
gies, work hour restrictions for trainees, lack of simulation 
equipment or facilities, and potential scarcity of skilled 
educators.
On these bases, the question of how properly warrant 
training should become pivotal so that physicians can be 
taught to the highest standards and patients can rely on 
the highest competency. Furthermore, the final assessment 
assigned to each trainee should not merely list the num-
ber of practical procedures performed, but rather provide 
a means of certifying the trainee’s level of competence.
indeed, the problem of unstructured and not standard-
ized training programs is a key issue worldwide with large 
heterogeneity amongst countries and teaching centers, and 
a general lack of competence certification for both fellows 
and skilled professionals, whose maintenance of compe-
tences should be regularly assessed.
different suggestions or requirements for determining 
competence are based on volume according to american 
college of Graduate medical education requirements and 
guidelines published by cHeST, the British Thoracic So-
ciety, and the american Thoracic Society/european respi-
ratory Society.115-119
But no conclusive consensus nor standardization has 
been reached yet. more recently, the american college 
Table III.— Summary of quantitative and qualitative assessment.119, 120
Quantitative 
assessment 
with logbook 
(minimum 
volume)
Number of procedures:
• (100 eBUS procedures according to 
accreditation standards reported in mullon et 
al.)119 50 procedures, after at least 100 flexible 
bronchoscopies and 5 TBNas
Qualitative 
assessment
• mcQ
• case-based questionnaire
• dOPS (eBUS STaT, eBUS SaT)
• assessment on patient:
• Balloon and needle set-up in all cases
• ability to pass scope through vocal cords in ±90% 
of cases
• ability to image lymph node in question in ±90% 
of cases
• Ability to pass TBNA needle through wall of 
trachea/bronchus into node in ±80%
• Typical procedure time: 30–40 min
• ERS-EBUS Certification Methodology www.
ersnet.org based on verification of pre-requisites 
and registration, theoretical interactive session, 
simulation training, supervised training in home 
institution, completion of 20 procedures and 3 
video procedures.
Outcome 
assessment
diagnostic yield: diagnostic samples containing 
sufficient material for molecular testing required for 
treatment guidance.
• Comparison with pathology staging
• Sensitivity for carcinoma in ±75% of cases
• Safety (<1% - bleeding, pneumothorax, 
infections)
competence 
maintenance (by 
LOGBOOK)
N. of procedures/year
• 20/year
• re-evaluation
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is likely to overcome all the above mentioned limitations. 
First, it let the beginner free to practice safely and with-
out supervision without any risk for patients and scopes; 
second, it provides a controlled, highly reproducible and 
standardized simulated settings and, finally, it allows to 
obtain number of performance metrics that can be used 
to objectively assess performance. Konge and colleagues 
have recently tested and validated a virtual reality simula-
tion metric set and concluded that, although discrimina-
tive abilities of currently available high fidelity simulators 
should be enforced, after a proper test design, a credible 
standard setting and appropriate transfer studies, virtual 
reality simulators would represent a pivotal innovation in 
first line training of beginners.126 Indeed, skills acquired by 
high fidelity virtual reality simulation can be detected by 
using other evaluation tools such as the already described 
eBUS-STaT124 and eBUSSaT111 questionnaires.
In a recent study, Scarlata and co-workers were able to 
demonstrate that virtual reality simulation facilitates prac-
tical learning among practitioners, and eBUS-STaT ques-
tionnaire is capable of detecting these improvements.124
The endoscopic Ultrasonography assessment Tool 
(eUSaT) used in eUS-FNa for mediastinal staging has 
been proposed as a tool also in the respiratory medicine 
environment. a study by Konge et al. shows the EUSAT 
can distinguish operators’ performances according to their 
level of experience, and the result appears to be repro-
ducible.127 However, further research is needed to realize 
whether the different learning curves existing between GI 
endoscopists and bronchoscopists in eUS might be affect-
ing the psycometric properties of this application.
Furthermore, it is likely that in the future the respiratory 
endoscopist will perform EUS mostly by using traditional 
linear EBUS or specifically developed “hybrid tracheo-
broncho-esophageal” instruments instead of the current, 
standard, EUS scope. It is unknown whether the EUSAT 
might be equally performed to measure proficiency in EUS-
B-FNa practitioners. Further research is needed to clarify 
this issue and, eventually, to develop dedicated tools.
In conclusion, it would be desirable for trainees to sys-
tematically have simulated training before commencing 
patient experience. But, there are difficulties, such as cost 
and accessibility, that have to be overcome. Furthermore, 
a technologic effort to expand current simulation platform 
is needed and future research should provide evidence and 
operational recommendation to address the best approach 
and warrant the highest level of education amongst prac-
titioners.
1) “Pattern recognition”; 2) “Handling of the endoscope, 
how to take biopsies.”122
To date, two different approaches have been validated in 
order to provide a qualitative assessment of competence in 
EBUS-TBNA. The first implies the use of dedicated ques-
tionnaires specifically developed to test the apprenticeship 
in EBUS-TBNA training. Basically, the two most wide-
ly available instruments are eBUS-STaT and eBUSaT. 
EBUS-STAT is an a 10-section unblinded, check list, test 
designed to evaluate the technical skill and relevant knowl-
edge of a physician performing convex probe EBUS- 
TBNA. Items 1–7 test technical skills, whereas items 8–10 
test cT scan and eBUS image recognition and correlation. 
it has been successfully validated and tested and can be 
used to classify eBUS-TBNa operators from novice to 
expert.123 moreover, it has proved suitable for assessing 
skills amelioration during a simulation-based training, 
especially for novices and those with no previous experi-
ence.124 This approach suffers from intrinsic limitation of 
which both trainers and trainees should be aware of: first, 
non blinded raters often introduce bias in the ratings and 
limit the evidence of validity to a lower level according 
to the Oxford Centre for Evidence-based Medicine levels 
of evidence.125 It is very likely, in fact, that raters will be 
influenced by non-objectives factors, such as the appear-
ance of the probands, their personal knowledge, or knowl-
edge of previous experience or training; second, check-list 
designed tools only allows “black-or-white” assessments 
of the more complicated and multifaceted technical skills 
that constitute an eBUS procedure. as a consequence, this 
might lead to a “ceiling effect” where more experienced 
operators’ improvement fails to be recognized. in other 
words, check-lists only register if a subpart of a procedure 
is performed, and not how well it is performed.
The second proposed questionnaire, the eBUS-SaT, is 
a 12-item tool in which each item is rated on a scale from 
one to five. Six items are designed to assess the knowledge 
of mediastinal anatomy by asking the operators to identify 
six anatomic landmarks (lymph node stations 4R, 4L, 7, 
10L or 11L, 10r or 11r and azygos vein). Four items are 
related to the technical skills necessary to handle the scope 
and perform TBNa (insertion of the endoscope, position-
ing of the transducer, use of sheath and use of needle).111 
Two items allow assessors to give their overall opinion on 
anatomic orientation and biopsy sampling. It allows for a 
blinded assessment of clinical eBUS-TBNa performance 
and, therefore, seems to be less influenced by external, 
subjective, sources of bias.
The third option, the use of a virtual reality simulator, 
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